10x Genomics EBITDA Margin 2018-2025 | TXG

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for 10x Genomics (TXG) over the last 10 years. The current EBITDA margin for 10x Genomics as of March 31, 2025 is .
10x Genomics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.63B $-0.13B -20.96%
2024-12-31 $0.61B $-0.15B -24.71%
2024-09-30 $0.63B $-0.16B -24.60%
2024-06-30 $0.63B $-0.21B -32.75%
2024-03-31 $0.63B $-0.23B -36.26%
2023-12-31 $0.62B $-0.22B -35.54%
2023-09-30 $0.59B $-0.19B -32.49%
2023-06-30 $0.57B $-0.14B -24.82%
2023-03-31 $0.54B $-0.15B -27.05%
2022-12-31 $0.52B $-0.14B -26.36%
2022-09-30 $0.50B $-0.13B -25.79%
2022-06-30 $0.50B $-0.11B -21.49%
2022-03-31 $0.50B $-0.06B -11.02%
2021-12-31 $0.49B $-0.03B -5.09%
2021-09-30 $0.46B $-0.42B -91.50%
2021-06-30 $0.41B $-0.47B -116.01%
2021-03-31 $0.33B $-0.50B -151.05%
2020-12-31 $0.30B $-0.52B -172.24%
2020-09-30 $0.26B $-0.12B -44.27%
2020-06-30 $0.25B $-0.06B -25.10%
2020-03-31 $0.26B $-0.04B -14.02%
2019-12-31 $0.25B $-0.02B -9.35%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.576B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.084B 57.36
Doximity (DOCS) United States $11.307B 52.35
Hims & Hers Health (HIMS) United States $10.719B 111.37
Tempus AI (TEM) United States $9.847B 0.00
IRhythm Technologies (IRTC) United States $4.340B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.717B 0.00
Privia Health (PRVA) United States $2.496B 170.58
Enovis (ENOV) United States $1.944B 10.84
Phreesia (PHR) United States $1.590B 0.00
Schrodinger (SDGR) United States $1.542B 0.00
Azenta (AZTA) United States $1.532B 71.21
Clover Health Investments (CLOV) United States $1.486B 0.00
Omnicell (OMCL) United States $1.344B 23.71
Evolent Health (EVH) United States $1.313B 111.80
Claritev (CTEV) United States $0.761B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.501B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.442B 132.00
Outset Medical (OM) United States $0.344B 0.00
TruBridge (TBRG) United States $0.331B 735.33
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Zepp Health (ZEPP) Netherlands $0.150B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.101B 3.84
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.068B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00